Pharma Industry Seeing Reduction in Data Breach Costs, But Still Have Much to Do

Insights from IBM’s Cost of a Data Breach Report on the Pharmaceutical Industry shows that while the overall cost has improved, there are clear areas of risk that need to be addressed.